StockTipsArenaBeta

BUY Procter & Gamble Health Limited — ICICI Securities

BUYProcter & Gamble Health Limited
Procter & Gamble Health share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)4 Nov 2026via Institutional / Brokerage Research

Entry₹5,738Inferred
Target₹6,680
Total upside +16.42%
Stop lossNot given
CMP₹5,5561d ago
Active-3.17%+20.23%upside left 12 mo left
Follow ICICI Securities for new calls(64% target hit, 1085 closed calls)Get alertsWatch PGHL for new buy/sell callsGet alertsSee 1 other Long-term call on PGHLSee 541 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:25 pm IST
6 supporting3 neutral1 opposing
Supports the BUY call (6)

Procter & Gamble Health reported Q2 results with sales of ₹376 crores (up 18% YoY) and Profit After Tax of ₹112 crores (up 26% YoY).

BSE · Company Update·2 Nov · 5d ago

(opens in new tab)

Procter & Gamble Health Ltd reported a net profit of 11,151 lakhs for the quarter ended September 30, 2026, compared to 8,854 lakhs in the same quarter of the previous year.

BSE · Result·2 Nov · 5d ago

(opens in new tab)

Procter & Gamble Health reported strong Q2 results for the quarter ended September 30, 2026, with sales increasing 18% to ₹376 crores and Profit After Tax (PAT) rising 26% to ₹112 crores.

NSE · Press Release·2 Nov · 5d ago

(opens in new tab)

Procter & Gamble Health Limited reported a net profit of 11,151 lakhs for the quarter ended September 30, 2026, compared to 8,854 lakhs in the same quarter of the previous year.

NSE · Outcome of Board Meeting·2 Nov · 5d ago

(opens in new tab)

Procter & Gamble Health reported a net profit of 11,151 lakhs for the quarter ended September 30, 2026, compared to 8,854 lakhs in the same quarter of the previous year.

BSE · Board Meeting·2 Nov · 5d ago

(opens in new tab)
Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·6 Nov · yesterday

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Procter & Gamble Health

All analyst calls on Procter & Gamble Health

More from ICICI Securities

Every call and its outcome